ACP is proud to be a supporting partner of Patient Community Day. Learn more and sign up.
Collage of photos: senior woman sitting on a bench thinking, a woman looking out an a rural open field, a man in a wheelchair looking out his window, and a group of three Black women with their arms around each other.

Limited representation limits research.

ACP connects researchers with communities underrepresented in research, so findings hold true for more of the people they're meant to help.

The gaps aren't random

Who participates in research is shaped by many factors — from where studies are conducted and who hears about them to eligibility criteria, participation barriers, bias, and mistrust rooted in past and present experiences. These barriers can leave some communities underrepresented and limit how well findings apply across the MS population.

More inclusive research starts here

Whether you need hands-on project support or broader tools and resources, ACP has you covered.

Six people sitting around a conference table engaging on a video call with participants.

Consult with community advisors

The Research, Inclusion, Diversity, and Equity (RIDE) Council brings nearly 30 people living with MS from underrepresented communities to the table. Available for project consulting at every stage of your study.

abstract image of interconnected blue nodes

Connect with a field-wide network

The MS Minority Research Engagement Partnership Network (MREPN) is a free, open network of researchers, clinicians, and community organizations working together to make MS research more representative.

The numbers behind the gap

These aren’t abstract disparities. They can shape who participates in research — and how useful the findings are for the people research is meant to serve.

> 50%

of people living with MS are 55+

Yet people over 50–55 have historically been excluded from randomized MS clinical trials. *

1 in 5

Americans live in rural areas

where distance can limit access to research centers and healthcare. *

93%

are white participants

among Phase 3 MS trials reporting race or ethnicity in a 2024 systematic review. *
* Sources: Tumani H, et al. Multiple Sclerosis and Related Disorders. 2023; Centers for Disease Control and Prevention, About Rural Health; Ponzano M, et al. Multiple Sclerosis Journal. 2024.

More ways ACP can support your research

More tools to support your research, wherever you are in the process.

Back to Top